Long-Term Safety Study of Vildagliptin in Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Novartis
Related studies linked through entity extraction aliases.
Pharmacokinetic Study on the Combination of Everolimus-Tacrolimus
- Status
- UNKNOWN
- Phase
- PHASE2
To Assess the Efficacy and Safety of Vildagliptin as Add-on Therapy to Sulfonylurea in Patients With Type 2 Diabetes Inadequately Controlled With Sulfonylurea Monotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects.
- Status
- COMPLETED
- Phase
- PHASE2
Estrogen Treatment in Acromegalic Women
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Effects of Vildagliptin on the Insulin Response to Glucose in Subjects With Pre-diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months
- Status
- COMPLETED
- Phase
- PHASE4
SPP100 Dose Finding Study in Japan
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months.
- Status
- COMPLETED
- Phase
- PHASE2
Kinetics of B Cell Response in Infants Menjugate Vaccination
- Status
- COMPLETED
- Phase
- PHASE4
Persistence of Immune Response After Vaccination With MCC
- Status
- COMPLETED
- Phase
- PHASE4